EU Clear Use of Janssen’s Treatment for Crohn’s Disease
With expanded approval of Janssen’s psoriasis blockbuster Stelara, individual patients in the EU with Crohn’s disease have gained possible access a new treatment option. Regulators in Europe have approved use of the biologic as an alternative option for adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost